Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
tonic parker[Author]
(43 results)?
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
JAMA Oncol. 2022 Aug 1;8(8):1177-1183. doi: 10.1001/jamaoncol.2022.2286.
JAMA Oncol. 2022.
PMID: 35737367
Free PMC article.
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.
Tarantino P, Ajari O, Graham N, Vincuilla J, Parker T, Hughes ME, Tayob N, Garrido-Castro AC, Morganti S, King TA, Mittendorf EA, Curigliano G, Lin NU, Tolaney SM.
Tarantino P, et al. Among authors: parker t.
Eur J Cancer. 2024 Apr;201:113920. doi: 10.1016/j.ejca.2024.113920. Epub 2024 Feb 10.
Eur J Cancer. 2024.
PMID: 38368741
Review.
Item in Clipboard
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.
Tarantino P, Niman SM, Erick TK, Priedigkeit N, Harrison BT, Giordano A, Nakhlis F, Bellon JR, Parker T, Strauss S, Jin Q, King TA, Overmoyer BA, Curigliano G, Regan MM, Tolaney SM, Lynce F.
Tarantino P, et al. Among authors: parker t.
Eur J Cancer. 2022 Oct;174:277-286. doi: 10.1016/j.ejca.2022.07.001.
Eur J Cancer. 2022.
PMID: 36116830
Item in Clipboard
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.
Morganti S, Jin Q, Vincuilla J, Buehler R, Ryan S, Stokes S, Parker T, Mittendorf EA, King TA, Weiss A, Partridge AH, Bychkovsky BL, Curigliano G, Tayob N, Lin NU, Garber JE, Tolaney SM, Lynce F.
Morganti S, et al. Among authors: parker t.
NPJ Breast Cancer. 2024 Apr 16;10(1):28. doi: 10.1038/s41523-024-00632-8.
NPJ Breast Cancer. 2024.
PMID: 38627457
Free PMC article.
Item in Clipboard
Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer.
Morganti S, Gibson CJ, Jin Q, Santos K, Patel A, Wilson A, Merrill M, Vincuilla J, Stokes S, Lipsyc-Sharf M, Parker T, King TA, Mittendorf EA, Curigliano G, Hughes ME, Stover DG, Tolaney SM, Weeks LD, Tayob N, Lin NU, Garber JE, Miller PG, Parsons HA.
Morganti S, et al. Among authors: parker t.
J Clin Oncol. 2024 Jan 8:JCO2301071. doi: 10.1200/JCO.23.01071. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38190580
Item in Clipboard
Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy.
Weiss A, King C, Vincuilla J, Parker T, Portnow L, Nakhlis F, Dominici L, Mittendorf EA, King TA.
Weiss A, et al. Among authors: parker t.
Breast Cancer Res Treat. 2022 Sep;195(2):181-189. doi: 10.1007/s10549-022-06677-2. Epub 2022 Jul 28.
Breast Cancer Res Treat. 2022.
PMID: 35900704
Item in Clipboard
Development of an Electronic Health Record Registry to Facilitate Collection of Commission on Cancer Metrics for Patients Undergoing Surgery for Breast Cancer.
Lyu HG, Kantor O, Laws AD, McDonald J, Pham L, Dominici LS, Vincuilla J, Raut CP, Danilchuk B, Novak L, Parker T, King TA, Mittendorf EA.
Lyu HG, et al. Among authors: parker t.
JCO Clin Cancer Inform. 2022 Oct;6:e2200012. doi: 10.1200/CCI.22.00012.
JCO Clin Cancer Inform. 2022.
PMID: 36215674
Free article.
Item in Clipboard
Cite
Cite